null / Credit: Oleksandr Lysenko/Shutterstock
Washington, D.C. Newsroom, Jun 13, 2025 / 10:56 am (CNA).
WomeninAmericaandtheUnitedKingdomaretakinglegalactionagainstPfizerandotherbirthcontrolproducersafterastudyindicatedthatinjectablecontraceptiveswerefoundtocausebraintumors.
Acasemanagementconferenceregardingthemulti-districtlitigationwasheldonMay30inPensacola,Florida,todiscussthenextstepsinthelawsuitsfiledagainstNewYork-basedPfizer.
Thelegalactionfollowsa2024Frenchstudythatfoundthattheuseofthecontraceptivemedicationmedroxyprogesterone,oftenknownunderPfizer’sbrandnameDepo-Provera,rendersawomanfivetimesmorelikelytodevelopameningiomabraintumor.
Meningiomasareslow-growingtumorsthatareusuallybenignbutcancausesevereinjuryordeathiftheybecomelargeenoughtocompressthebrainorspinalcord.
TheresearchstudyconductedbytheNationalAgencyforMedicinesandHealthProductsSafetyexamineddataon18,061women.Theparticipantswereonaveragearound57yearsoldandhadallundergoneintracranialsurgeriesformeningiomasbetween2009and2018.